ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.480del (p.Cys161fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV004577688 SCV005061697 pathogenic Glanzmann thrombasthenia 2024-06-06 reviewed by expert panel curation The NM_000419.5(ITGA2B):c.480del (p.Cys161AlafsTer22) (also referred as "c.512delC") variant in ITGA2B is a deletion in exon 4, resulting in a shift of the reading frame and a premature stop signal (p.Cys161Alafs*22). This variant is predicted to cause a premature stop codon in biologically relevant exon (exon 4) leading to nonsense mediated decay (PVS1). This variant has been detected in trans with a pathogenic variant NM_000419.4:c.1654del (mentioned as "c.1686delG" in the article) in an individual with Glanzmann thrombasthenia (PMID: 27416581; PM3). The patient (PMID: 27416581) displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia (PP4_moderate). Additionally, αIIbβ3 surface expression was absent, as measured by flow cytometry. This variant is absent from gnomAD v4.1.0 population databases (PM2_Supporting). In summary this variant meets criteria to be classified as Pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PVS1, PM3, PM2_Supporting, PP4_Moderate.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.